• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The roles of HLA genes relevant to gene therapy for human melanoma.

Research Project

Project/Area Number 05670733
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Dermatology
Research InstitutionYamaguchi University

Principal Investigator

MUTO Masahiko  Yamaguchi Univ.Sch.Med., Dept.Dermat.Associate Professor, 医学部, 助教授 (40175625)

Co-Investigator(Kenkyū-buntansha) MOGAMI Satoshi  Yamaguchi Univ.Sch.Med., Dept.Dermat.Assistant, 医学部, 助手 (30253149)
HAMAMOTO Yoshiaki  Yamaguchi Univ.Sch.Med., Dept.Dermat.Lecturer, 医学部・附属病院, 講師 (90238080)
ASAGAMI Chidori  Yamaguchi Univ.Sch.Med., Dept.Dermat.Professor, 医学部, 教授 (80035188)
Project Period (FY) 1993 – 1994
Project Status Completed (Fiscal Year 1994)
Budget Amount *help
¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 1994: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 1993: ¥1,300,000 (Direct Cost: ¥1,300,000)
KeywordsHuman melanoma / Disease susceptibility / HLA polymorphism / Gene therapy
Research Abstract

It has not been clear whether HLA antigens are associated with malignant melanoma in Japan. Acral lentiginous melanoma (ALM) may occur in Japanese but is uncommon in Caucasians. In order to elucidate involvement of HLA genes relevant to development of melanoma, we performed an HLA population survey, by using peripheral blood lymphocytes obtained from 58 unrelated Japanese patients with melanoma (20 nodular melanoma (NM) , 20 ALM,9 superficial spreading melanoma, 4 lentigo maligna melanoma, 4 melanoma derived from the membrane and 1 metastatic melanoma) . The results showed that there was a strong association between melanoma and HLA-B13 (p<0.0001) and Cw6 (p<0.03) . In NM,the frequency of HLA-B13 was extremely high. An increased frequency of HLA-B51 was seen in ALM (9/20=45 (%) vs 15/120=13 (%) in normal control) . In contrast, its frequency in NM was extremely decreased (1/20=5 (%) ) . HLA-B61 was decreased in a total of the melanomas. Thus, HLA-linked immune response or immune suppression gene (s) appear to contribute to the susceptibility to human melanoma. There might be genetic differences between NM and ALM.

Report

(3 results)
  • 1994 Annual Research Report   Final Research Report Summary
  • 1993 Annual Research Report
  • Research Products

    (7 results)

All Other

All Publications (7 results)

  • [Publications] Masahiko Muto,et al.: "Major histocompatibility complex class I-associated susceptibility to malignant melanoma." J.Invest.Dermatol. 102. 579- (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Masahiko Muto,et al.: "HLA-B13 is a melanogenesis-related molecule." J.Dermatol.Sci.8. 87- (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Muto, M., et al.: "Major histocompatibility complex class I-associated susceptibility to malignant melanoma." J.Invest.Dermatol.102. 579 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Muto, M., et al.: "HLA-B13 is a melanogenesis-related molecule." J.Dermatol.Sci.8. 87 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Masahiko Muto,et al.: "Major histocompatibility complex class I-associated susceptibility to malignant melanoma." J.Invest.Dermatol.102. 579 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] Masahiko Muto,et al.: "HLA-B13 is a melanogenesis-related molecule." J.Dermatol.Sci.8. 87 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] Muto,M.et al.: "Major histocompatibility complex class I associated susceptibility to malignant melanoma." Journal of Investigative Dermatology. 102 (in press). (1994)

    • Related Report
      1993 Annual Research Report

URL: 

Published: 1993-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi